ArticleiScience2026

SeSA-HCPT: A dual-targeting agent that induces DNA damage and inhibits repair for castration-resistant prostate cancer therapy.

Yajie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.